Latest Period
Q1 2026
Security Snapshot
CervoMed Inc. - Common Stock, par value $0.001 per share (CRVO) Institutional Ownership
CUSIP: 15713L109
13F Institutional Holders and Ownership History from Q3 2023 to Q1 2026
Institutions Reporting
35
Shares (Excl. Options)
1,769,590
Price
$3.94
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- CRVO on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,769,590
- Total 13F value
- $6,972,142
- Portfolio coverage rank
- 0%
- Share change
- -434,340
- Value change
- -$5,532,974
- Number of holders
- 35
- Shares outstanding
- 11,020,715
- SEC-reported price per share
- $3.14
- Insider filing price
- $3.14
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CRVO - CervoMed Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 15713L109.
- 35 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 48 to 35 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $17,410,591 to $6,972,142.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 35 institutions filings for Q1 2026.
Security key
15713L109
Latest holder period
Q1 2026
13F holders
35
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
CRVO full holder history
CervoMed Inc. SEC filings
CervoMed Inc. company facts
CervoMed Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 15713L109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
CRVO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BOGER JOSHUA S | 20% | $8,309,619 | 2,204,143 | BOGER JOSHUA S | 11 Jun 2026 | |||
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $8,646,810 | +$933,559 | 1,026,937 | +12% | RA Capital Management, L.P. | 30 Jun 2025 |
| MORGAN STANLEY | 8% | +58% | $2,966,341 | +$1,066,881 | 739,736 | +56% | Morgan Stanley | 31 Mar 2026 |
| AWM Investment Company, Inc. | 4.2% | -57% | $1,596,350 | -$1,804,658 | 405,165 | -53% | AWM Investment Company, Inc. | 31 Mar 2026 |
As of 31 Mar 2026, 35 institutional investors reported holding 1,769,590 shares of CervoMed Inc. - Common Stock, par value $0.001 per share (CRVO). This represents 16% of the company’s total 11,020,715 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
16%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | 6.7% | 739,892 | +56% | 0% | $2,915,175 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.9% | 316,202 | 0% | 0% | $1,245,836 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 208,908 | +247% | 0% | $823,098 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.67% | 74,371 | +13% | 0% | $293,092 |
| RENAISSANCE TECHNOLOGIES LLC | 0.58% | 63,904 | 0% | $251,782 | |
| BlackRock, Inc. | 0.47% | 51,660 | +5.1% | 0% | $203,540 |
| XTX Topco Ltd | 0.35% | 38,487 | +273% | 0% | $151,639 |
| CITIZENS FINANCIAL GROUP INC/RI | 0.34% | 37,477 | 0% | 0% | $147,659 |
| VANGUARD FIDUCIARY TRUST CO | 0.33% | 36,151 | 0% | 0% | $142,435 |
| NORTHERN TRUST CORP | 0.27% | 30,044 | -2% | 0% | $118,373 |
| Cetera Investment Advisers | 0.25% | 27,337 | 0% | 0% | $107,708 |
| Savvy Advisors, Inc. | 0.24% | 25,922 | 0% | 0% | $102,133 |
| STATE STREET CORP | 0.19% | 20,527 | 0% | 0% | $80,876 |
| JANE STREET GROUP, LLC | 0.17% | 18,246 | +65% | 0% | $71,889 |
| Russell Investments Group, Ltd. | 0.15% | 16,090 | 0% | 0% | $63,395 |
| Byrne Asset Management LLC | 0.13% | 14,700 | 0% | 0.03% | $57,918 |
| HighTower Advisors, LLC | 0.1% | 11,265 | +0.19% | 0% | $44,384 |
| FMR LLC | 0.1% | 11,040 | -2.5% | 0% | $43,498 |
| THOMPSON DAVIS & CO., INC. | 0.09% | 10,000 | 0% | 0.03% | $39,400 |
| UBS Group AG | 0.05% | 5,239 | +402% | 0% | $20,641 |
| NFSG Corp | 0.03% | 3,000 | 0% | 0% | $11,820 |
| Vanguard Global Advisers, LLC | 0.02% | 2,597 | 0% | 0% | $10,232 |
| Tower Research Capital LLC (TRC) | 0.02% | 2,178 | +309% | 0% | $8,581 |
| Federation des caisses Desjardins du Quebec | 0.02% | 1,700 | 0% | $6,698 | |
| HOEY INVESTMENTS, INC | 0.01% | 1,080 | 0% | 0% | $4,256 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q1 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,769,590 | $6,972,142 | -$5,532,974 | $3.94 | 35 |
| 2025 Q4 | 2,203,903 | $17,410,591 | +$558,220 | $7.90 | 48 |
| 2025 Q3 | 2,132,491 | $17,251,242 | +$167,312 | $8.09 | 44 |
| 2025 Q2 | 2,173,154 | $13,657,601 | -$929,086 | $6.28 | 42 |
| 2025 Q1 | 2,283,166 | $20,892,111 | +$8,828,449 | $9.15 | 46 |
| 2024 Q4 | 1,485,110 | $3,460,093 | -$33,750,758 | $2.34 | 42 |
| 2024 Q3 | 3,505,695 | $51,185,917 | +$596,925 | $14.60 | 48 |
| 2024 Q2 | 3,446,957 | $59,012,261 | +$15,847,476 | $17.12 | 38 |
| 2024 Q1 | 2,514,408 | $58,586,040 | +$50,991,141 | $23.30 | 20 |
| 2023 Q4 | 326,440 | $2,481,528 | -$46,092 | $7.63 | 12 |
| 2023 Q3 | 363,667 | $1,681,783 | +$1,681,783 | $4.62 | 12 |